Angela Hildreth
Director of Finance/CFO at FUTURA MEDICAL PLC
Net worth: 73 088 $ as of 2024-03-30
Profile
Angela Hildreth currently holds multiple positions as CFO, COO, Secretary & Executive Director, Secretary & Director, and Director at Futura Medical Plc, Futura Medical Developments Ltd., Futura Consumer Healthcare Ltd., and Quaff Box Ltd.
respectively.
In the past, she worked as a Director at Phosphate Therapeutics Ltd.
and Shield TX (UK) Ltd.
She also served as Senior Independent Director at Aptamer Group Plc and as Group Financial Controller & Head-Human Resources at Shield Therapeutics Plc from 2011 to 2017.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FUTURA MEDICAL PLC
0.05% | 2023-04-05 | 142,857 ( 0.05% ) | 73 088 $ | 2024-03-30 |
APTAMER GROUP PLC
-.--% | 2023-06-29 | 0 ( -.--% ) | - $ | 2024-03-30 |
Angela Hildreth active positions
| Companies | Position | Start |
|---|---|---|
| FUTURA MEDICAL PLC | Director of Finance/CFO | 2018-02-19 |
Futura Medical Developments Ltd.
 Futura Medical Developments Ltd. BiotechnologyHealth Technology Futura Medical Developments Ltd. develops pharmaceutical products for both the prescription and consumer healthcare markets. The company is headquartered in Guildford, the United Kingdom. | Director/Board Member | 2018-02-19 |
| Futura Consumer Healthcare Ltd. | Director/Board Member | 2018-02-19 |
| Quaff Box Ltd. | Director/Board Member | 2017-03-05 |
Former positions of Angela Hildreth
| Companies | Position | End |
|---|---|---|
| APTAMER GROUP PLC | Director/Board Member | 2023-08-20 |
Phosphate Therapeutics Ltd.
 Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Director/Board Member | 2017-12-07 |
Shield TX (UK) Ltd.
 Shield TX (UK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Shield Therapeutics Plc, Shield TX (UK) Ltd. is a British pharmaceutical company founded in 2008. The private company is based in Gateshead, UK. Shield TX (UK specializes in developing innovative specialty pharmaceuticals to address significant unmet needs in the treatment of iron deficiency. The company's clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make the difference in their everyday lives. Visitors can browse their library of results, reports, and presentations on their website and sign up for investor news alerts. | Director/Board Member | 2017-12-07 |
| SHIELD THERAPEUTICS PLC | Director of Finance/CFO | 2017-11-30 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| FUTURA MEDICAL PLC | Health Technology |
| SHIELD THERAPEUTICS PLC | Health Technology |
| Private companies | 6 |
|---|---|
Futura Medical Developments Ltd.
Futura Medical Developments Ltd. BiotechnologyHealth Technology Futura Medical Developments Ltd. develops pharmaceutical products for both the prescription and consumer healthcare markets. The company is headquartered in Guildford, the United Kingdom. | Health Technology |
Phosphate Therapeutics Ltd.
Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Health Technology |
Shield TX (UK) Ltd.
Shield TX (UK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Shield Therapeutics Plc, Shield TX (UK) Ltd. is a British pharmaceutical company founded in 2008. The private company is based in Gateshead, UK. Shield TX (UK specializes in developing innovative specialty pharmaceuticals to address significant unmet needs in the treatment of iron deficiency. The company's clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make the difference in their everyday lives. Visitors can browse their library of results, reports, and presentations on their website and sign up for investor news alerts. | Health Technology |
| Aptamer Group Plc | |
| Futura Consumer Healthcare Ltd. | |
| Quaff Box Ltd. |
- Stock Market
- Insiders
- Angela Hildreth
